Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.115 USD | -1.74% | +5.24% | +75.99% |
May. 14 | Taysha Gene Therapies Q1 Net Loss Narrows, Revenue Declines -- Shares Down After Hours | MT |
May. 14 | Transcript : Taysha Gene Therapies, Inc., Q1 2024 Earnings Call, May 14, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+75.99% | 585M | |
+52.36% | 58.06B | |
-3.86% | 40.53B | |
+38.14% | 38.99B | |
-12.01% | 26.56B | |
+14.13% | 26.7B | |
-21.62% | 18.98B | |
+0.21% | 12.17B | |
+25.96% | 11.92B | |
+23.02% | 12B |
- Stock Market
- Equities
- TSHA Stock
- News Taysha Gene Therapies, Inc.
- Earnings Flash (TSHA) TAYSHA GENE THERAPIES Reports Q1 Revenue $3.4M, vs. Street Est of $2.6M